NEW YORK, NY — On the evening of October 13, 2026, the global skyline will undergo a dramatic transformation. From the towering heights of One World Trade Center in Manhattan to the historic arches of the Ness Bridge in Scotland, more than 325 landmarks across 50 U.S. states and 20 countries will be bathed in a specific triad of colors: teal, green, and pink. This synchronized display marks the 2026 iteration of #LightUpMBC, a global campaign spearheaded by METAvivor Research and Support to bring visibility to the often-overlooked realities of Metastatic Breast Cancer (MBC).
As National Metastatic Breast Cancer Awareness Day approaches, the campaign seeks to pivot the conversation from general "awareness" toward urgent "action." While October is widely recognized as Breast Cancer Awareness Month—a period dominated by pink ribbons and messages of early detection—the MBC community is using this day to highlight a grimmer reality: for those with Stage 4 cancer, there is currently no cure, and early detection was either not possible or failed to prevent the disease’s spread.
Main Facts: A Global Movement for Stage 4 Research
The #LightUpMBC campaign is more than a visual spectacle; it is a strategic fundraising and advocacy initiative. This year’s event is slated to be the largest in the organization’s history, spanning 195 cities worldwide. The colors chosen for the illumination are deeply symbolic: teal represents healing and spirituality; green symbolizes hope, renewal, and the "land" where life continues; and pink signifies the breast cancer origin of the disease.
The centerpiece of the evening is #LightUpMBC Live, a high-production virtual broadcast scheduled for 8 p.m. ET / 5 p.m. PT. The program, which will be streamed across YouTube, Facebook Live, and LiveOne, serves as a bridge between the clinical world of oncology and the personal lives of those living with the disease. Hosted by MBC advocate Tami Eagle Bowling and Broadway veteran Kara Lindsay, the event will feature a mix of scientific briefings, patient testimonials, and performances by Tony Award-winning artists.
Critically, 100% of the net proceeds from the campaign are funneled directly into metastatic breast cancer research. Unlike many broader breast cancer charities that allocate significant portions of their budgets to awareness, education, or early-stage research, METAvivor focuses exclusively on Stage 4, aiming to transition the disease from a terminal diagnosis to a manageable, chronic condition.
Chronology: From a Single Bridge to a Global Network
The origins of #LightUpMBC are rooted in a personal story of friendship and loss. The campaign was founded by Laura Inahara in honor of her best friend, Jessica Moore, who was diagnosed with metastatic breast cancer at the age of 32 and passed away just four years later.
Jessica Moore’s initial wish was modest: she hoped to see one local landmark illuminated to acknowledge the unique struggles of MBC patients. In 2017, that wish was granted when the Memorial Bridge in Portsmouth, New Hampshire, turned teal, green, and pink. What began as a localized tribute quickly resonated with a community that felt largely invisible during the "Pink October" festivities.
By 2018 and 2019, the initiative began to scale, partnering with METAvivor to provide a national platform. The campaign’s growth has been exponential:
- 2017: One landmark in New Hampshire.
- 2020-2022: Despite the challenges of the global pandemic, the campaign moved into the digital sphere, launching the #LightUpMBC Live broadcast to reach patients isolated by health risks.
- 2023-2025: The number of participating landmarks surpassed 200, reaching international territories including the Philippines, Canada, and the United Kingdom.
- 2026: The current campaign hits a record-breaking 325+ landmarks, having raised a cumulative total of over $2.7 million for research since its inception.
Supporting Data: The Stark Reality of MBC
To understand the urgency of the #LightUpMBC campaign, one must look at the epidemiological data surrounding metastatic disease. Metastatic breast cancer occurs when cancer cells break away from the original tumor in the breast and travel through the lymphatic system or bloodstream to other parts of the body. The most frequent sites of metastasis are the bones, liver, lungs, and brain.
According to projections for 2026, the statistics remain sobering:
- Mortality: An estimated 42,670 people in the United States are expected to die from breast cancer this year. This equates to approximately 117 deaths every single day.
- Staging: While early detection is a vital tool, approximately 6% of new breast cancer cases are "de novo" metastatic, meaning the cancer has already spread at the time of the initial diagnosis.
- Recurrence: For those diagnosed at earlier stages (Stages 1-3), nearly 30% will eventually see their cancer return as metastatic disease, sometimes decades after being declared "cancer-free."
- Funding Disparity: Historically, only 2% to 5% of overall breast cancer research funding has been dedicated to metastatic disease, despite it being the cause of nearly all breast cancer deaths.
METAvivor’s mission is to close this funding gap. By utilizing a rigorous peer-review process—where both scientific experts and patient advocates evaluate grant applications—the organization ensures that money is directed toward the most promising treatments for Stage 4 patients.
Official Responses: Leadership and Advocacy
The leadership at METAvivor emphasizes that while the lights are beautiful, the objective is survival. Dr. Kelly Shanahan, a physician and the Board President of METAvivor, provides a unique perspective as both a medical professional and a patient.
"When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan stated. "My hope and the hope of so many others lies in research. METAvivor-funded research is increasingly important because it focuses on the biology of why cancer spreads and how to stop it. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community that often feels left behind by the ‘pink ribbon’ narrative."
Laura Inahara, the campaign’s founder, reflected on the legacy of Jessica Moore. "Jessica’s hope was to illuminate the path for others. Today, her legacy helps families around the world shine a light for the people they love. It has taught patients how to advocate for themselves and has raised the critical funds needed to change the statistics."
Tami Eagle Bowling, the Campaign Director and a survivor living with MBC for 11 years, highlighted the importance of the live broadcast. "We are bringing together Broadway stars, world-renowned scientists, and patients sharing their stories from the very landmarks being lit. It’s a night of collective power. We are showing the world that we are here, we are living, and we need more time."
Implications: Changing the Trajectory of a Terminal Diagnosis
The implications of the #LightUpMBC campaign extend far beyond the night of October 13. The $2.7 million raised thus far has funded dozens of research grants aimed at identifying new drug targets, understanding treatment resistance, and improving the quality of life for those on "forever treatments."
For the pharmaceutical and medical communities, the visibility generated by #LightUpMBC serves as a reminder of the patient-centric demand for innovation. As more landmarks join the movement, the pressure increases on federal funding bodies and private institutions to reallocate resources toward Stage 4 research.
The campaign also has significant psychological implications for the MBC community. For many patients, the traditional "Pink October" focus on "beating cancer" or "survivorship" can be alienating, as their treatment never ends. The teal, green, and pink lights provide a sense of belonging and validation, acknowledging that their journey is different but equally important.
As the world prepares to watch the Willis Tower, Niagara Falls, and the Mactan-Cebu Airport glow in MBC colors, the message is clear: awareness is the first step, but research is the only way to save lives. The #LightUpMBC campaign has successfully turned a personal tribute into a global powerhouse of advocacy, ensuring that the 117 people lost every day are honored not just with silence, but with a vibrant, glowing call for a cure.
How to Participate:
The public is encouraged to visit participating landmarks on October 13, take photographs, and share them on social media using the hashtags #LightUpMBC and #METAvivor. The live broadcast can be accessed via www.lightupmbc.org, where viewers can also find a full list of participating locations and make donations to support Stage 4 research.
About the Author
